It is the combination of family history of both tylosis and oesophageal cancer, late onset skin lesions (i.e. substantially after birth but before puberty) and, more recently, the demonstration of mutation in RHBDF2 that enable differential diagnosis [12]. This evidence concerns the gene RHBDF2 and Non-epidermolytic palmoplantar keratoderma.